Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing <it>klebsiella pneumoniae</it> in patients on maintenance hemodialysis

Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing <it>klebsiella pneumoniae</it> in patients on maintenance hemodialysis

<p>Abstract</p> <p>Background</p> <p>Hemodialysis (HD) patients are susceptible to extended spectrum beta-lactamase (ESBL)-producing bacterial infections. Because the optimal treatment and clinical significance of ESBL-producing <it>Klebsiella pneumoniae</it>...

Full description

Bibliographic Details
Main Authors: Yang Chih-Chao, Li Shau-Hsuan, Chuang Feng-Rong, Chen Chih-Hung, Lee Chih-Hsiung, Chen Jin-Bor, Wu Chien-Hsing, Lee Chien-Te
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Infectious Diseases
Subjects:
Bacteremia
Carbapenems
Extended spectrum beta-lactamase
Flomoxef
Hemodialysis access
<it>Klebsiella pneumoniae</it>
Online Access:http://www.biomedcentral.com/1471-2334/12/206

Internet

http://www.biomedcentral.com/1471-2334/12/206

Similar Items